Seeking Alpha

GlaxoSmithKline (GSK) Q2: Core EPS 26.4 pence. Sales -3.9% to £6.46B vs. consensus of...

GlaxoSmithKline (GSK) Q2: Core EPS 26.4 pence. Sales -3.9% to £6.46B vs. consensus of £6.65B. Net profit +13% to £1.25B vs. consensus of £1.34B. Increases dividend by 6% to 17 pence. Shares -0.85%. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector